Sangamo Therapeutics
SGMO
SGMO
115 hedge funds and large institutions have $642M invested in Sangamo Therapeutics in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 18
4% more funds holding
Funds holding: 111 → 115 (+4)
Holders
115
Holding in Top 10
5
Calls
$93.6M
Puts
$10.5M
Top Buyers
| 1 | +$15.6M | |
| 2 | +$14.7M | |
| 3 | +$13.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.94M |
| 5 |
Jennison Associates
New York
|
+$5.85M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$7.34M | |
| 3 | -$2.91M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.47M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.24M |